0.9889
price down icon3.99%   -0.0411
after-market Handel nachbörslich: .99 0.0011 +0.11%
loading

Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten

pulisher
Jul 23, 2025

Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser

Jul 21, 2025
pulisher
Jul 20, 2025

ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

How Virax Biolabs Group Limited stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ATCH stock attracts strong analyst attentionFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Virax Biolabs Group Limited stock attracts strong analyst attentionFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Virax Biolabs Group Limited stock price move sharplyHigh Probability Setups - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 0.7% – Time to Buy? - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - simplywall.st

Jul 04, 2025
pulisher
Jun 13, 2025

Virax Biolabs Announces CFO Resignation and Transition - TipRanks

Jun 13, 2025
pulisher
Jun 10, 2025

FibroBiologics names new CFO after going public last year - The Business Journals

Jun 10, 2025
pulisher
May 24, 2025

Kaival Brands Innovations Group (NASDAQ:KAVL) Trading Down 1.2% – Time to Sell? - Defense World

May 24, 2025
pulisher
May 24, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 2% – Here’s What Happened - Defense World

May 24, 2025
pulisher
Apr 25, 2025

Virax Biolabs Group (NASDAQ:VRAX) Trading Up 6.9% – Here’s What Happened - Defense World

Apr 25, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 04, 2025

FY2025 Earnings Estimate for VRAX Issued By HC Wainwright - Defense World

Apr 04, 2025
pulisher
Apr 01, 2025

Virax Biolabs Group (NASDAQ:VRAX) Coverage Initiated by Analysts at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Virax Biolabs Group Ltd.’s Innovative Diagnostics and Strategic Collaborations Justify Buy Rating - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

ELISpot and FluoroSpot Assay Market Size to Hit USD 576.59 Million by 2034 - Precedence Research

Mar 28, 2025
pulisher
Mar 22, 2025

Virax Biolabs Group (NASDAQ:VRAX) Stock Price Down 3.9% – What’s Next? - Defense World

Mar 22, 2025
pulisher
Mar 18, 2025

Virax Biolabs Launches Clinical Study on T Cell Dysfunction - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Virax Biolabs begins UK clinical study on T cell dysfunction - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough T Cell Study: Virax Targets Long COVID and Chronic Fatigue Diagnosis Revolution - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Virax Biolabs shares T-Cell dysfunction findings - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Virax Biolabs shares T-Cell dysfunction findings By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Game-Changing Long COVID Diagnostic: Virax's New T-Cell Test Shows Promising Results - StockTitan

Mar 13, 2025
pulisher
Mar 05, 2025

Virax Biolabs to Present at World Immune Regulation Meeting - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Can Virax's T-Cell Research at WIRM 2025 Advance Post-Infection Syndrome Treatment? - StockTitan

Mar 05, 2025
pulisher
Mar 01, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Up 205.8% in February - The AM Reporter

Mar 01, 2025
pulisher
Feb 28, 2025

Cosmos Health expands distribution of Avian Influenza kits - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Expands By 205.8% - Defense World

Feb 28, 2025
pulisher
Feb 25, 2025

Virax Biolabs aligns with US vaccine transparency efforts By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Virax Biolabs Aligns with US Health Department on Vaccine Transparency - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

How Virax's Vaccine Testing Tech Could Capitalize on New Government Transparency Push - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency - Benzinga

Feb 25, 2025
pulisher
Feb 20, 2025

Contrasting Virax Biolabs Group (NASDAQ:VRAX) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Feb 20, 2025
pulisher
Feb 10, 2025

Market Watch: Virax Biolabs Group Ltd (VRAX)’s Noteworthy Drop, Closing at 1.71 - The Dwinnex

Feb 10, 2025
pulisher
Feb 02, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 33.9% in January - Armenian Reporter

Feb 02, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):